Literature DB >> 18497424

Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors.

Li Li1, Patricia A Thompson, Richard L Kitchens.   

Abstract

Apolipoprotein E (apoE) plays important roles in lipid homeostasis, anti-inflammation, and host defense. Since tissue apoE mRNA levels have been reported to decrease during inflammatory responses, we were surprised to find that plasma apoE levels were significantly elevated during septic infections in both humans and mice. This apparent paradox was also observed during lipopolysaccharide-induced acute inflammation in mice: plasma levels of apoE increased up to 4-fold despite sharply decreased apoE gene expression in the liver, macrophages, and extrahepatic tissues. We hypothesized that apoE levels were augmented by decreased plasma clearance. Our analysis revealed that apoE associated principally with HDL in mice and that apoE was cleared from the circulation principally via LDL receptors. The acute inflammatory response decreased LDL receptor expression in the liver and significantly reduced the rate of apoE clearance. In contrast, the same inflammatory stimuli increased LDL receptor expression in macrophages. Our results define a novel acute phase mechanism that increases circulating apoE levels as apoE production decreases. Diminished hepatic LDL receptor expression may thus cooperate with elevated LDL receptor expression in macrophages to facilitate the forward transport of apoE and its associated lipids to these key defense cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497424      PMCID: PMC2444006          DOI: 10.1194/jlr.M800172-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

Review 1.  Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.

Authors:  M C Jong; M H Hofker; L M Havekes
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

2.  Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.

Authors:  H G Kraft; H J Menzel; F Hoppichler; W Vogel; G Utermann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Apolipoprotein-mediated pathways of lipid antigen presentation.

Authors:  Peter van den Elzen; Salil Garg; Luis León; Manfred Brigl; Elizabeth A Leadbetter; Jenny E Gumperz; Chris C Dascher; Tan-Yun Cheng; Frank M Sacks; Petr A Illarionov; Gurdyal S Besra; Sally C Kent; D Branch Moody; Michael B Brenner
Journal:  Nature       Date:  2005-10-06       Impact factor: 49.962

4.  APOE polymorphism is associated with risk of severe sepsis in surgical patients.

Authors:  Eugene W Moretti; Richard W Morris; Mihai Podgoreanu; Debra A Schwinn; Mark F Newman; Ellen Bennett; Victor G Moulin; Uzo U Mba; Daniel T Laskowitz
Journal:  Crit Care Med       Date:  2005-11       Impact factor: 7.598

5.  Apolipoprotein E suppresses the type I inflammatory response in vivo.

Authors:  Kamilah Ali; Melissa Middleton; Ellen Puré; Daniel J Rader
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

Review 6.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

7.  Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.

Authors:  N de Bont; M G Netea; P N Demacker; I Verschueren; B J Kullberg; K W van Dijk; J W van der Meer; A F Stalenhoef
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

8.  Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.

Authors:  David J Grainger; Jill Reckless; Elaine McKilligin
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

9.  Serial analysis of gene expression in human monocytes and macrophages.

Authors:  S Hashimoto; T Suzuki; H Y Dong; N Yamazaki; K Matsushima
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

10.  Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice.

Authors:  T Arai; F Rinninger; L Varban; V Fairchild-Huntress; C P Liang; W Chen; T Seo; R Deckelbaum; D Huszar; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

View more
  29 in total

1.  Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix.

Authors:  Jimmy F P Berbée; Claudia P Coomans; Marit Westerterp; Johannes A Romijn; Louis M Havekes; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

2.  Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients.

Authors:  Sheila A Alexander; Dianxu Ren; Scott R Gunn; Patrick M Kochanek; Judith Tate; Milos Ikonomovic; Yvette P Conley
Journal:  Am J Crit Care       Date:  2014-01       Impact factor: 2.228

3.  ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.

Authors:  Patricia A Thompson; Karine C Gauthier; Alan W Varley; Richard L Kitchens
Journal:  J Lipid Res       Date:  2010-05-15       Impact factor: 5.922

Review 4.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

5.  Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta.

Authors:  Armando Sena; Klaus Bendtzen; Maria J Cascais; Rui Pedrosa; Véronique Ferret-Sena; Elisa Campos
Journal:  J Neurol       Date:  2010-06-04       Impact factor: 4.849

6.  Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants.

Authors:  Pak Cheung Ng; Irene Ling Ang; Rossa Wai Kwun Chiu; Karen Li; Hugh Simon Lam; Raymond Pui On Wong; Kit Man Chui; Hon Ming Cheung; Eddy Wing Yin Ng; Tai Fai Fok; Joseph Jao Yiu Sung; Yuk Ming Dennis Lo; Terence Chuen Wai Poon
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

Review 7.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31

8.  Inflammation impairs reverse cholesterol transport in vivo.

Authors:  Fiona C McGillicuddy; Margarita de la Llera Moya; Christine C Hinkle; Michelle R Joshi; Elise H Chiquoine; Jeffrey T Billheimer; George H Rothblat; Muredach P Reilly
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

9.  Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein.

Authors:  Patricia A Thompson; Jimmy F P Berbée; Patrick C N Rensen; Richard L Kitchens
Journal:  Innate Immun       Date:  2008-12       Impact factor: 2.680

10.  Inflammation stimulates the expression of PCSK9.

Authors:  Kenneth R Feingold; Arthur H Moser; Judy K Shigenaga; Sophie M Patzek; Carl Grunfeld
Journal:  Biochem Biophys Res Commun       Date:  2008-07-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.